IGC Pharma | 8-K:重大事件
IGC Pharma | 4:持股變動聲明-董事 Moran James P
IGC Pharma | 8-K:重大事件
IGC Pharma | SC 13D/A:超過5%持股股東披露文件(修正)-Bradbury Strategic Investment Fund A(18.3%)
IGC Pharma | 4:持股變動聲明-董事 PRINS RICHARD K
IGC Pharma | 144:擬議出售證券
IGC Pharma | 10-Q:2025財年一季報
IGC Pharma | UPLOAD:其他
IGC Pharma | 8-K:重大事件
IGC Pharma | DEFA14A:其他
IGC Pharma | DEF 14A:股東委託書決議
IGC Pharma | 10-K:2024財年年報
IGC Pharma | SC 13D:超過5%持股股東披露文件-Bradbury Strategic Investment Fund A(18.3%)
IGC Pharma | 4:持股變動聲明-股東 Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
IGC Pharma | 3:首次持股聲明- Bradbury Strategic Investment Fund A (Cayman Islands Registration No. CR-359857)
IGC Pharma | EFFECT:其他
IGC Pharma | CORRESP:信函
IGC Pharma | UPLOAD:其他
IGC Pharma | S-3:特定交易註冊聲明
IGC Pharma | 8-K:重大事件
暫無數據
暫無數據